RXRX icon

Recursion Pharmaceuticals
RXRX

Overview Fund Activity

133 hedge funds and large institutions have $861M invested in Recursion Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 45 increasing their positions, 33 reducing their positions, and 21 closing their positions.

Holders
133
Holders Change
+5
Holders Change %
+3.91%
% of All Funds
2.25%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.14%
New
29
Increased
45
Reduced
33
Closed
21
Calls
$499K
Puts
$588K
Net Calls
-$89K
Net Calls Change
-$132K

Top Buyers

1
MCMU
1
MIC Capital Management (UK)
United Kingdom
$68.8M
2
Norges Bank
2
Norges Bank
Norway
$34.6M
3
BlackRock
3
BlackRock
New York
$67.1M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$23.1M
5
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$3.26M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$2.5M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$186K
3
CC
3
Casdin Capital
New York
$0
4
Baillie Gifford & Co
4
Baillie Gifford & Co
United Kingdom
$176M
5
Voloridge Investment Management
5
Voloridge Investment Management
Florida
$450K
Name Market Value Shares Shares
Change 		Shares
Change %
Charles Schwab
26
Charles Schwab
California
$3.49M 428,342 +55,178 +15%
Sumitomo Mitsui Trust Group
27
Sumitomo Mitsui Trust Group
Japan
$3.26M 399,901 +399,901 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$3.25M 399,353 +25,653 +7%
NAMA
29
Nikko Asset Management Americas
New York
$3.24M 399,901 -15,367 -4%
Millennium Management
30
Millennium Management
New York
$3.12M 383,174 -111,978 -23%
Mitsubishi UFJ Trust & Banking
31
Mitsubishi UFJ Trust & Banking
Japan
$3.04M 373,390 – –
Citadel Advisors
32
Citadel Advisors
Florida
$2.5M 307,372 -602,598 -66%
PCM
33
Pentwater Capital Management
Florida
$2.44M 300,000 – –
Lazard Asset Management
34
Lazard Asset Management
New York
$2.36M 289,609 +100,685 +53%
DFO
35
Duquesne Family Office
New York
$2.23M 273,650 – –
SB
36
Samsara BioCapital
California
$2.18M 267,996 -271,240 -50%
Renaissance Technologies
37
Renaissance Technologies
New York
$2.13M 261,600 +83,200 +47%
Morgan Stanley
38
Morgan Stanley
New York
$1.81M 221,704 +81,107 +58%
AO
39
Allen Operations
New York
$1.77M 217,657 – –
Goldman Sachs
40
Goldman Sachs
New York
$1.6M 196,067 -13,342 -6%
ECM
41
ExodusPoint Capital Management
New York
$1.56M 192,073 +158,360 +470%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$1.54M 188,666 +64,774 +52%
Mariner
43
Mariner
Kansas
$1.42M 174,537 +146,418 +521%
SSA
44
Schonfeld Strategic Advisors
New York
$1.4M 172,195 +81,395 +90%
JPMorgan Chase & Co
45
JPMorgan Chase & Co
New York
$1.38M 169,350 +42,311 +33%
Rafferty Asset Management
46
Rafferty Asset Management
New York
$1.11M 136,626 +32,977 +32%
Russell Investments Group
47
Russell Investments Group
United Kingdom
$1.05M 128,537 +128,537 New
Hudson Bay Capital Management
48
Hudson Bay Capital Management
Connecticut
$977K 120,000 -80,000 -40%
Swiss National Bank
49
Swiss National Bank
Switzerland
$918K 112,800 +18,500 +20%
Legal & General Group
50
Legal & General Group
United Kingdom
$914K 112,337 +47,649 +74%
1
2
3 4 5